Skip to main content
padlock icon - secure page this page is secure

Molecular Genetics and Epidemiology of Osteoporosis

Buy Article:

$68.00 + tax (Refund Policy)



Although various environmental factors, including diet and physical exercise, influence bone mass, a genetic contribution to this parameter has also been recognized. Genetic linkage analyses and candidate gene association studies have implicated several loci, and a variety of candidate genes in the regulation of bone mineral density and the pathogenesis of osteoporosis or osteoporotic fracture. However, the genes responsible for these latter conditions have not been identified definitively. I here summarize both the candidate loci identified by linkage analyses and the candidate genes examined by association studies. I also review in more detail studies that have examined the association with bone mass or with the susceptibility to osteoporosis or osteoporotic fracture of polymorphisms in the genes for the vitamin D receptor, collagen type Iα1, estrogen receptor α, interleukin-6, osteocalcin, osteoprotegerin, CC chemokine receptor 2, matrix metalloproteinase-1, and transforming growth factor-α1. Such studies may provide insight into the function of these genes as well as into the role of genetic factors in the development of osteoporosis.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: influence bone mass; molecular genetics; transforming growth factor; vitamin d receptor

Document Type: Review Article

Publication date: June 1, 2003

More about this publication?
  • Current Pharmacogenomics provides comprehensive overviews of all current research on pharmacogenomics and pharmacogenetics. All areas of the field from pre-clinical to clinical research are covered, including related areas such as genomics, proteomics, target discovery, bioinformatics and novel diagnostics. This international journal is peer-reviewed and publishes both mini- and full review articles.

    The journal has become essential reading for all researchers and clinicians with interests in pharmacogenomics and pharmacogenetics.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more